{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T16:56:25Z","timestamp":1790787385777,"version":"4.1.0"},"reference-count":9,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,3,21]],"date-time":"2025-03-21T00:00:00Z","timestamp":1742515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,21]],"date-time":"2025-03-21T00:00:00Z","timestamp":1742515200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s12185-025-03965-7","type":"journal-article","created":{"date-parts":[[2025,3,23]],"date-time":"2025-03-23T00:46:41Z","timestamp":1742690801000},"page":"862-865","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["DLI-induced remission in recurrent EBV-associated T\/NK-cell lymphoproliferative disease following HSCT: a case report"],"prefix":"10.1007","volume":"121","author":[{"given":"Toru","family":"Nagata","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirohito","family":"Kubota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2932-4960","authenticated-orcid":false,"given":"Itaru","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazushi","family":"Izawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryo","family":"Akazawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyasu","family":"Jo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuyuki","family":"Arai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shohei","family":"Azumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuya","family":"Kamitori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Saida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsutsugu","family":"Umeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken-Ichi","family":"Imadome","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Yasumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidefumi","family":"Hiramatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junko","family":"Takita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,21]]},"reference":[{"issue":"7","key":"3965_CR1","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","volume":"36","author":"R Alaggio","year":"2022","unstructured":"Alaggio R, Amador C, Anagnostopoulos I, Attygalle AD, Araujo IBO, Berti E, et al. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: lymphoid Neoplasms. Leukemia. 2022;36(7):1720\u201348. https:\/\/doi.org\/10.1038\/s41375-022-01620-2. (published correction appears in Leukemia. 2023 Sep;37(9):1944-1951).","journal-title":"Leukemia."},{"issue":"3","key":"3965_CR2","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1182\/blood-2011-10-381921","volume":"119","author":"H Kimura","year":"2012","unstructured":"Kimura H, Ito Y, Kawabe S, Gotoh K, Takahashi Y, Kojima S, et al. EBV-associated T\/NK-cell lymphoproliferative diseases in nonimmunocompromised hosts: prospective analysis of 108 cases. Blood. 2012;119(3):673\u201386. https:\/\/doi.org\/10.1182\/blood-2011-10-381921.","journal-title":"Blood"},{"issue":"4","key":"3965_CR3","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1007\/s12185-017-2192-6","volume":"105","author":"A Sawada","year":"2017","unstructured":"Sawada A, Inoue M, Kawa K. How we treat chronic active Epstein-Barr virus infection. Int J Hematol. 2017;105(4):406\u201318. https:\/\/doi.org\/10.1007\/s12185-017-2192-6.","journal-title":"Int J Hematol"},{"issue":"6","key":"3965_CR4","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1038\/s41409-020-01193-7","volume":"56","author":"N Wei","year":"2021","unstructured":"Wei N, Wang Y, Wang J, Wu L, Wang Z. Characteristics of Epstein-Barr virus reactivation after allogeneic haematopoietic stem cell transplantation in patients with chronic active Epstein-Barr virus disease: favorable responses to rituximab. Bone Marrow Transpl. 2021;56(6):1449\u201351. https:\/\/doi.org\/10.1038\/s41409-020-01193-7.","journal-title":"Bone Marrow Transpl"},{"issue":"4","key":"3965_CR5","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1182\/blood-2003-05-1513","volume":"103","author":"KS Peggs","year":"2004","unstructured":"Peggs KS, Thomson K, Hart DP, Geary J, Morris EC, Yong K, et al. Dose-escalated donor lymphocyte infusions following reduced intensity transplantation: toxicity, chimerism, and disease responses. Blood. 2004;103(4):1548\u201356. https:\/\/doi.org\/10.1182\/blood-2003-05-1513.","journal-title":"Blood"},{"issue":"12","key":"3965_CR6","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1038\/s41409-023-02103-3","volume":"58","author":"PPM Vaswani","year":"2023","unstructured":"Vaswani PPM, Onozawa M, Hasegawa Y, Ohigashi H, Ara T, Matsukawa T, et al. Incidence and course of Epstein-Barr virus viremia after allogeneic hematopoietic stem cell transplant for adult-onset systemic chronic active Epstein-Barr virus disease. Bone Marrow Transplant. 2023;58(12):1397\u20139. https:\/\/doi.org\/10.1038\/s41409-023-02103-3.","journal-title":"Bone Marrow Transplant"},{"key":"3965_CR7","doi-asserted-by":"publisher","first-page":"7","DOI":"10.21037\/aol-20-34","volume":"5","author":"A Sawada","year":"2021","unstructured":"Sawada A, Inoue M. Narrative review of chronic active EBV infection\u2014advances in clinical management. Ann Lymphoma. 2021;5:7. https:\/\/doi.org\/10.21037\/aol-20-34.","journal-title":"Ann Lymphoma"},{"issue":"1","key":"3965_CR8","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/sj.bmt.1704074","volume":"32","author":"F Yoshiba","year":"2003","unstructured":"Yoshiba F, Hagihara M, Tazume K, Ogawa Y, Kishi K, Higuchi A, et al. Complete resolution of severe chronic active Epstein-Barr virus infection by cultured, activated donor T lymphocyte infusion after nonmyeloablative stem cells allografting. Bone Marrow Transpl. 2003;32(1):107\u201310. https:\/\/doi.org\/10.1038\/sj.bmt.1704074.","journal-title":"Bone Marrow Transpl"},{"issue":"4","key":"3965_CR9","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1002\/ped4.12350","volume":"6","author":"Y Luo","year":"2022","unstructured":"Luo Y, Wei A, Wang B, Zhu G, Zhang R, Jia C, et al. Allogeneic hematopoietic stem cell transplantation with the modified myeloablative conditioning regimen for children with chronic active Epstein-Barr virus infection. Pediatr Investig. 2022;6(4):250\u20139. https:\/\/doi.org\/10.1002\/ped4.12350.","journal-title":"Pediatr Investig"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-025-03965-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12185-025-03965-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-025-03965-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T11:32:19Z","timestamp":1748259139000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12185-025-03965-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,21]]},"references-count":9,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["3965"],"URL":"https:\/\/doi.org\/10.1007\/s12185-025-03965-7","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,21]]},"assertion":[{"value":"11 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}